Blood draw only

OTHER2 trials

Sponsors

Bavarian Nordic, University of Southern California

Conditions

Critical Limb IschemiaSmallpox

Phase 2

An Open-Label Phase II Study to Evaluate Immunogenicity and Safety of a Single IMVAMUNE Booster Vaccination Two Years After the Last IMVAMUNE Vaccination in Former POX-MVA-005 Vaccinees

CompletedNCT00686582

Bavarian NordicSmallpox

Start: 2008-08-31End: 2009-06-30Updated: 2019-03-13

Unknown Phase

Aspirin and Clopidogrel Reactivity in Patients With Critical Limb Ischemia (CLI)

CompletedNCT02094755

University of Southern CaliforniaCritical Limb Ischemia

Start: 2013-06-19End: 2017-01-31Updated: 2019-06-28

Related Papers

LB1579. A single and a two-dose regimen of MVA-BN elicit similar memory responses to a boost vaccination two years after the initial regimen, indicating potential flexibility for a delayed second dose of MVA-BN in the ongoing monkeypox emergency

Open Forum Infectious Diseases2022-12-011 citations

One- and Two-Dose Vaccinations With Modified Vaccinia Ankara-Bavarian Nordic Induce Durable B-Cell Memory Responses Comparable to Replicating Smallpox Vaccines

The Journal of Infectious Diseases2022-11-2150 citations